Abbott Launches Next-Gen FreeStyle Libre® 2 Plus with Continuous Glucose Readings Every Minute & Optional Alarms
Tuesday, 26 August 2025 ()
*Business Wire India*
· People can feel more confident managing their diabetes with Abbott’s world-leading continuous glucose monitoring system[1], now with real-time glucose readings and optional alarms.
· With continuous glucose readings and customizable alarms, the FreeStyle Libre ^® 2 Plus gives peace of mind [2] to people with diabetes and caregivers.
Abbott, the global healthcare company, today announced the launch of the FreeStyle Libre 2 Plus sensor, Abbott’s latest addition to the FreeStyle Libre sensor portfolio. This innovative device offers automatic glucose readings every minute straight to your phone, empowering people with diabetes to manage their condition with confidence, precision, and ease. People living with diabetes can see their glucose readings, without having to scan, and receive alerts automatically on their compatible[3] smartphone when low glucose levels [4] or high glucose levels4 happen, letting them make informed decisions. With 101 million people living with diabetes, India is home to the second-largest diabetes population in the world.[5] This staggering number highlights the urgent need for accessible, real-time tools like continuous glucose monitors (CGMs) to help people manage their diabetes confidently and proactively. Glucose monitoring, alongside appropriate therapy, is key to managing the condition and preventing complications.[6] “Abbott’s pioneering FreeStyle Libre technology is transforming the way diabetes is managed for over seven million individuals across the globe. We are thrilled to introduce this life-changing innovation to India, where it holds immense potential to empower people to be able to manage the condition better,” said *Dr. Kenneth Lee, Regional Medical Affairs Director, Asia Pacific, Diabetes Division, Abbott.* “FreeStyle Libre2 Plus performance meets robust accuracy standards [7]^,[8] to ensure reliable glucose readings for all intended patient populations and glycemic ranges. It gives people the freedom to monitor their glucose levels without routine fingersticks, helping them make more informed decisions.” Studies show that FreeStyle Libre technology can help reduce low blood sugar episodes by up to 43%[9], a 0.9% to 1.5% drop in HbA1c levels[10], and even cut hospital visits by 66%[11]. Libre technology has been shown to reduce cardiovascular complication risk by 78%[12] in people with Type 1 diabetes post-severe hypoglycemia, and lower hospitalization risk for stroke and diabetes-related complications by 44%[13] in insulin-treated Type 2 diabetes.[14]. And for caregivers, real-time alerts offer peace of mind and the chance to act before situations get serious. *How The FreeStyle Libre 2 Plus Works* The FreeStyle Libre 2 Plus uses near-field communication (NFC) and bluetooth technology with optional alarms providing continuous glucose data to a compatible smartphone. [15]^,[16] Sensor can be worn on the back of the arm for up to 15 days and can be activated via a quick scan using a compatible phone. People living with diabetes see real-time glucose levels every minute, historical trends and patterns, and arrows showing where glucose levels are going without having to fingerstick[17]. Parents and caregivers can also automatically receive glucose readings and set customizable alarms helping provide further peace of mind. Additionally, people using FreeStyle LibreLink can share information with their healthcare professional and caregivers through LibreView and LibreLinkUp, digital health tools that are also part of the FreeStyle Libre platform. LibreView is a secure, cloud-based diabetes management system that enables the patient to share their glucose insights with their healthcare provider helping him take timely intervention. LibreLinkUp is a mobile app for parents and caregivers, allowing them to easily check glucose history and trends for a child, elderly parent or loved ones managing diabetes. “I’ve always believed in the power of technology. But it wasn’t until my mother-in-law was diagnosed with diabetes that I truly understood how transformative the right tools can be. We were constantly worried about sudden drops in her sugar levels, especially at night or when she was alone,” says *Sameera Reddy, Actor & Influencer*. “Using the FreeStyle Libre 2 Plus has changed it all. The real-time accurate updates, the alerts, the ability to track trends—it gave us back a sense of control. I could be away for work and still know she was okay. She feels more confident and more independent. That kind of reassurance is priceless."
FreeStyle Libre 2 Plus is now available across India for adults and children aged 2 and above, including women with gestational diabetes. *About FreeStyle Libre systems* Abbott continues to pioneer ground-breaking technology to support people living with diabetes. The company revolutionized diabetes care 10 years ago with its world-leading FreeStyle Libre continuous glucose monitoring portfolio, which today is used by more than 7 million people across over 60 countries[18]. People use Libre technology to see their glucose numbers in real-time, providing insights into how food, activity, or insulin impacts their glucose to help them make progress on their health goals. There is full or partial reimbursement for Libre systems in more than 40 countries[19].
--------------------
[1] Data on file, Abbott Diabetes Care. Based on the number of patients assigned to each manufacturer.
[2] Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142
[3] https://freestyleserver.com/Payloads/IFU/2025/q2/ART39109-001_rev-BC-pub.pdf
[4] Low glucose is defined as 140 mg/dL; ADA (American Diabetes Association), CDA (Canadian Diabetes Association) and EMA (European Medicines Agency)
[5] https://www.thelancet.com/pdfs/journals/landia/PIIS2213-8587(23)00119-5.pdf
[6] Diabetes leads to complication. 2. David M. Williams et al., Stroke 2023; 54(5):1441-1451. https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.042109
[7] Based on publicly available information from FDA databases accessed on January 2025, for iCGM products available at https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-862/subpart-B/section-862.1355. iCGM is a US-only classification and regulation
[8] Klonoff, D. C. Journal of Diabetes Science and Technology (2024). https://doi.org/10.1177/19322968241250357
[9] REPLACE study - Haak, T. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6
[10] WRING Study - Wright E, Kerr MSD, Reyes IJ, et al. HbA1c reduction associated with a FreeStyle Libre system in people with type 2 diabetes not on bolus insulin therapy [78-LB]. Poster presented at: 80th Scientific c Sessions of the American Diabetes Association: June 12-16, 2020; Virtual
[11] Fokkert, M. BMJ Open Diab Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809
[12] https://link.springer.com/article/10.1007/s00125-025-06438-y
[13] https://link.springer.com/article/10.1007/s00125-024-06289-z
[14] Eeg-Olofsson, K., Diabetologia (2025): https://doi.org/10.1007/s00125-025-06438-y
[15] Glucose readings are automatically displayed in the FreeStyle LibreLink app only when user's smartphone and sensor are connected and in range.
[16] The FreeStyle LibreLink app is compatible with NFC-enabled smartphones running Android OS 5.0 or higher, and with iPhone 7 and higher running OS 11 and higher. The FreeStyle LibreLink app and the FreeStyle Libre reader have similar, but not identical, features.
[17] A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels, or if hypoglycemia or impending hypoglycemia is reported but the symptoms do not match the system readings
[18] Data on file, Abbott Diabetes Care. Based on the number of patients assigned to each manufacturer.
[19] Data on file, Abbott Diabetes Care.
*Dr Kenneth Lee, Dr. Eileen Canday, Sameera Reddy, & her mother-in-law Manjri Varde at FSL2 Plus launch event**About Abbott* Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals, and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at Abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube.
|
||||
|
|
||||
You Might Like |
||||
